Skip to content
Home/Companies/Biotech/Graph Therapeutics
GT

Graph Therapeutics

Biotech·Austria·Active·2yr hold

Graph Therapeutics is a biotech company, headquartered in Austria.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Graph Therapeutics?

Graph Therapeutics is currently owned by Merantix Capital through Merantix Capital AI Fund (2026 vintage), since 2024.

Hand-verified · updated 2026-07-03

Merantix Capital
Investor
Merantix Capital
Merantix Capital AI Fund · 2026 · VC

Key facts

HQAustria
SectorBiotech
StatusActive

More from Merantix Capital AI Fund

Other portfolio companies in the same fund.

WhyBrilliant
Active
SoftwareGermany· 2026
Arqh
Active
LogisticsSwitzerland· 2025
Droidrun
Active
SoftwareGermany· 2025
Outpost Bio
Active
BiotechUnited Kingdom· 2025
Ficus Health
Active
HealthcareGermany· 2024
revel8
Active
CybersecurityGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings